TESTOSTERONE and XY chromosomes are NOT enough to make someone a "normal" man
You need:
- XY chromosomes
- SRY gene
- sensitive androgen receptors
- functioning LH receptors
- 5 alpha reductase
- normal aromatase
- 17β-Hydroxysteroid dehydrogenase III
+ more
Anything missing can lead to DSD (differences in sex development)
Let’s examine the step by step process and what happens when things go off course 👇🧵
disclaimer: this is not a commentary on who is or isn't a man
This is just a step by step journey of all the things that need to go right for "normal" masculine development, from conception to birth to puberty
the concept of intersex is complex, and researching this blew my mind
DSD, sometimes referred to as intersex is often distinctly different than transgender
ok lets begin 👇
Step 1:
XY chromosomes
there are 23 pairs of chromosomes
The last pair are the sex chromosomes
Females are XX
Males are XY
Simple, right?
I wish…
Step 2: SRY gene
The key gene that leads to sexual differentiation is the SRY gene on the Y chromosome
The presence of this gene lead to masculinization, including the development of testicles and secondary male characteristics
But here's where it gets messy...
Technically, everyone starts out as a female as an embryo with "ovaries" but the SRY gene program leads to the transformation of "ovaries" into testicles and their descent out of the body into the scrotum
Sometimes the SRY gene is missing or inactive on Y chromosome, rendering it inactive
This leads to Sywer syndrome or XY complete gonadal dysgenesis
Born XY, but without testicles
Appear female externally but have problems with puberty, end up needing progesterone/estrogen to enhance female characteristics
A karyotype on these patient would be confusing
Now the OPPOSITE can also happen
The SRY gene can MOVE from the Y chromosome to the X chromosome
This leads to a patient who is XX but has testicles thanks to the SRY gene
This is called XX male or de la Chapelle syndrome
These patients are normal males externally but are infertile with small testicles. Hard to diagnose
In the past the Olympics would test for SRY genes to prove that only females were competing but this became controversial and was stopped after the 2000 games
A lot of false positives and confusing results
Step 3: Normal androgen receptor
The androgen receptor is what allows testosterone to induce its biological effect on gene transcription
Androgen receptor insensitivity is when someone has XY and SRY intact, but the receptor to testosterone is NOT working
If the receptor is functioning, the body can't fully experience the effects of testosterone, regardless of how high it is
1 of every 20,000 to 30,000 males has a 46,XX karyotype with the SRY gene, so its possible someone reading this is a case 🧐
The androgen receptor is what allows testosterone to induce its biological effect on gene transcription
There is a spectrum of androgen receptor insensitivity, ranging from mild to complete
Mild (MAIS) can lead to decreased male secondary characteristics while complete (CAIS) leads to looking externally like a female, despite sky high testosterone levels
Side note: There is a spectrum of androgen receptor sensitivity even among normal males, with some males being more sensitivity than others
This explains the very large variation in male testosterone and the difficulty in diagnosing symptoms of low testosterone
Some races are on average more sensitive
Step 4: 5 alpha reductase
Even with XY, SRY, normal androgen receptor, you NEED DHT
5 alpha reductase (5ar) converts testosterone into the more active DHT, which is ESSENTIAL for virilization
DHT in utero is essential for the development of male characteristics
5ar deficiency leads to DSD
These patients are born looking as females externally because not enough DHT was present during development to cause external male characteristics
This is what is being speculated that certain olympic athletes have, but there is NO CONFIRMATION of this
During puberty, the surge in testosterone leads to more masculinization as this is able to slightly overcome the lack of DHT
DHT is not active in the muscles, so these patients would look female but with more male musculature given they have sufficient testosterone levels
In fact, in a remote village in the Dominican Republic called Las Salinas there are many cases of this condition
They are initially raised as girls, but around age 12 they develop male characteristics. They are known locally as guabidós or guevedoces
Side note: This is story provided the idea for the drug Finasteride, which was developed by Merck
Step 5: Normal LH receptor
The brain makes LH which tells the testicles to make testosterone
There is a rare condition called Leydig cell hypoplasia where the LH receptor is not functioning
These patients partially or fully underdeveloped genitalia and infertility
Step 6: Normal steroid conversion enzyme
The first of which is Aromatase
It converts testosterone into estrogen. However two problems can arise:
1. XX females, too LOW aromatase end up with not enough estrogen and too much testosterone, leading to enlarged clitoris
2. XY males, too HIGH aromatase can lead to high estrogen and more female secondary characteristics such as gynecomastia
Another important enzyme is 17β-hydroxysteroid dehydrogenase III
This converts Androstenedione into testosterone in adrenals and testicles. Low levels can lead to lower testosterone and difficulties with secondary male characteristics
The steroid interplay from the adrenal glands to gonads is fascinating and many things can go wrong, such as congenital adrenal hyperplasia, but that affects XX females
Miscellaneous
On top of the six steps above, there can be other anomalies that occur that affect sexual development, such as Klienfelters XXY, where there is an extra x chromosome
Additionally, rarely some patients have mosaicism, where part of their body is XX and another part is XY
These patients sometimes have ovaries AND testicles, leading to Ovotesticular syndrome
As you can see, so many things can go wrong on the development of the typical masculine phenotype and its truly a miracle that the majority of men have normal male development
This was not meant to be comprehensive and there are more examples of DSD, which I will be posting about in coming days
Normally these cases are extremely RARE but because of their involvement in sports and the current cultural climate, more people are aware and discuss them
Understanding the nuances and complexities surrounding DSD can help better respect and address these patients
Please let me know if there are other threads on similar topics you would like to see!
If you enjoyed this, please repost the first tweet in this thread
The Truth about BPC-157: Why it isn’t FDA Approved and Why It Will Never Be
BPC-157 is one of the hottest compounds on the market right now with many people, especially in the bodybuilding and functional medicine space swearing by its beneficial effects for gut health and joint healing, among a whole host of other proposed possible benefits.
It is not however, a FDA approved pharmaceutical. Clinicians are prescribing it through compounding pharmacies without a clear, approved indication and people are buying it as a “research chemical” for “not human consumption” online. After ending up on the FDA “do not compound” list in late 2023, sources of injectable BPC have become scarce. Some have relabeled it as Pentadecapeptide Aringate or PDA (changing the acetate to an arginate) and are prescribing it for subcutaneous administration that way, while the confusion about its status has led to a vibrant oral capsule market for BPC in what appears to be a grey area of legality. (did the FDA accidentally make this into an OTC supplement by adding it to the do not compound list?)
So if it's so effective, why is it not approved by the FDA for human use? Is there some sort of conspiracy against “good” medicines that have potential to “heal” by big pharma? Are they worried it may cut into the profits of their other drugs, such as NSAIDs, PPIs, and biologics?
While those who stand to profit from BPC-157 sales on the internet would have you believe that, the answer is no.
As far as I can tell in my deep inquiry there is no global conspiracy against BPC-157. There are, however, simple economics of drug development processes that make it so BPC-157 likely will never go through the full process of drug approval because of financial incentives.
I would even venture to believe that a pharmaceutical company like Merck would LOVE to have the exclusive rights to BPC-157. However, because of the patents being filed and the way patents work on small peptides, pushing BPC through the entire FDA product, which would cost millions of dollars, is not going to happen.
Let’s look at how we got here:
BPC-157 is not new. Croatian researchers isolated the full, larger peptide BPC in 1998 from gastric juices and found the 15 amino acid sequence, BPC-157 to be the active part responsible for its clinical effects (the story of how it was discovered is fascinating, but that is a conversation for a different day if there is enough interest, let me know below). The first human safety study on health volunteers was conducted in 2002 and a “phase 2” double blind, randomized clinical trial (small and not sufficient for US phase 2 purposes) was conducted in 2005 with BPC-157 enemas for ulcerative colitis, with some promising effects (see research name PL 14736 to find the references). Yes, there were human studies with BPC-157 showing no known adverse effects and safety, however since those two initial trials it appears almost all the data has been in animal models, with a few, small studies here and there for human use.
If only 10% of the animal data on BPC-157 ends up being valid and applicable to humans, this is a blockbuster drug/compound that has great potential for human use. But this also may be part of the problem of pushing BPC through regulatory constraints (yes BPC-57 is suffering from success).
To get a drug FDA approved, a company must conduct phase 1, 2 and 3 clinical trials proving safety and efficacy of the compound through a laborious, multi year and extremely costly process. We’re talking a decade or more and hundreds of millions of dollars. The drug needs to be proven to work for a specific disease indication to get approval, while BPCs effects seem to be pleiotropic and the research cannot seem to focus on one, singular disease case to focus on.
Diagen is the company that currently owns the BPC-157 US patent (the European patent is expired), which was filed in 2012, approved in 2017 with an expected expiration of 2033. These are all the conditions listed in the patent:
Conditions and Disorders: 1. Stress-Related Diseases & Disorders 2. Gastrointestinal Conditions
• Ulcers in any part of the gastrointestinal tract
• General anti-inflammatory activity
• Gastrointestinal inflammatory diseases
• Crohn’s disease
• Acute pancreatitis 3. Organoprotective Needs
• Diseases, conditions, or disorders requiring organoprotective activity 4. Viral Infections
• Hepatitis A
• Herpes strains
• Influenza A
• Arthropod-borne (ARBO) viruses, including:
• Tick-borne encephalitis
• West Nile fever
• Dengue (types 1-4)
• Cytomegalovirus (CMV)
• Lymphocytic choriomeningitis (LCM) virus
• Feline leukemia virus 5. Oncology & Tumors
• Melanoma and related tumors 6. Tissue & Wound Healing
• Accelerated healing of wounds, burns, and bone fractures
• Regeneration of ruptured nerve linkages
• Achilles tendon and muscle repair
• Spinal cord injury recovery 7. Nitric Oxide (NO)-Related Disorders
• Hypertension
• Hypotension
• Anaphylaxis
• Circulatory and septic shock
• Thrombocyte aggregation 8. Neurological & Autoimmune Disorders
• Multiple sclerosis
• Myasthenia gravis
• Lupus erythematosus
• Neuropathy
• Somatosensory nerve dysfunction
• Asthma
• Rhinitis
• Pemphigus
• Eczema 9. Neurochemical & Substance-Related Disorders
• Catecholaminergic dysfunction
• Schizophrenia
• Withdrawal effects from amphetamines, drugs, and alcohol 10. Corticosteroid & NSAID-Related Disorders 11. Ophthalmological Conditions
• Squamous degeneration of the macula 12. Vascular & Circulatory Needs
• Conditions requiring rapid reorganization of blood supply 13. Animal Health & Reproductive Enhancement
• Weight gain in animals
• Increased sperm stability in storage (in animals) 14. Liver & Pancreatic Conditions
• Hepatic and pancreatic lesions
While this list seems impressive, BPC-157 would have a much easier time coming to market if one disease state was focused on and pushed through the regulatory process. Then, more off label uses could be found.
So why isn’t Diagen pushing this amazing molecule through regulation if its so effective? Are they cash strapped? It appears so, as they are actually trying to sell the BPC patent.
So then why doesn’t another big pharmaceutical company swoop in, buy the patent, and use their exhaustive funds to get BPC FDA approved, then make billions of dollars selling the drug to an already interested market. Because big pharma is evil? Not really.
If BPC-157 was purchased today, the patent would likely expire in 2033 before the phase 1-2-3 trials would be completed, at which point all the generic manufacturers would be able to push the product on the back of all the hard work a pharmaceutical company can do (I’m not sure if FDA approval would push the expiration of the patent back, but even then it would not be so financial lucrative).
On top of this, the market is already flush with BPC-157. Why would a company work so hard for this drug when people are getting it cheaply through compounded and grey/black market sources. Diagen seems unable to go after and sue all these people despite owning the patent, while Eli Lily with their deep pockets is going after GLP-1 compounders.
To complicate things further, over the last few years, several patents have come up for different use cases and applications of BPC-157. Because of the way patents for small peptides work, anyone can make a small change to a molecule, adding one amino acid here or there and now have a competing product that would not fall under the patent. For example, N-acetylated versions of BPC-157 will likely be pushed through for patent soon. Why would anyone spend a decade and hundreds of millions of dollars when tomorrow someone will make a small change to it and have their own product?
To get it FDA approved would require someone who so believes in the effects of BPC-157 to cough up a nice chunk of cash and support the research for its potential (I’m still bullish) restorative effects. To get it approved, you would need to:
1. Buy the patent (its for sale) 2. Figure out a specific disease indication to apply for BPC-157 approval 3. Hire a research team to run phase 1, 2, 3 trials
The financial incentives make it so that BPC-157 will likely never go through the full FDA approval process, which is a shame given how promising this compound is.
It is also a shame given the risk calculations in my mind for these small, short chain peptides is far different than a traditional pharmaceutical drug, given this is, in some ways, replacing/replenishing an endogenous gastric peptide that appears to decrease with age/stress. Given the human trials in early 2000’s showed no adverse events, despite using enormous doses, and the animal data corroborating this, many practitioners feel comfortable prescribing/recommending BPC-157 (I am not making such a recommendation).
The best hope for BPC is that this new regulatory environment allows for oral versions of the peptide to continue as OTC supplements (no GRAS indication has been given) while injectable forms are prescribed with modifications through compounding pharmacies as PDA or N-acetyl-BPC-157. And if we are lucky, someone with deep pockets will experience beneficial effects of this drug and decide to fund these studies themselves for the betterment of humanity.
This could easily go south if new safety concerns were brought forward for oral/injectable forms or impurities in the production by those who are seeking to profiteer off of this compound lead to adverse events. The large telehealth and compounding companies could fund this research to help people become more comfortable with using this compound.
If you’re interested, you can buy the BPC-157 patent here, before it expires early next decade. bpc157.si/bpc-157-stable…
In summary:
- BPC-157 is a promising compound for different cytoprotective uses
- It is not FDA approved for human use
- There is not some shadow cabal blocking the use of BPC-157
- Financial incentives make it so that BPC-157 is challenging to push through the regulatory process
- It will likely never receive FDA approval, but will be available in some form as oral supplement or through compounding pharmacies, with some modification
This is not medical advice. I am not suggesting you use BPC-157. It is not a FDA approved as a drug and the safety profile is still not clear. Discuss this with your doctor, with the hope that your doctor is aware of what BPC-157 is or find a doctor that is comfortable with this compound.
Slightly longer version with sources hyperlinked available on my blog
TLDR:
- BPC-157 is a promising compound for different cytoprotective uses
- It is not FDA approved for human use
- There is not some shadow cabal blocking the use of BPC-157
- Financial incentives make it so that BPC-157 is challenging to push through the regulatory process
- It will likely never receive FDA approval, but will be available in some form as oral supplement or through compounding pharmacies, with some modification, with unclear risks
This is the thread 🧵 I never thought I’d have to write
But with so many people cheering on for WW3 and our politicians treating human blood so cheaply
☢️HOW TO SURIVE NUCLEAR FALLOUT ☢️
(You’re going to want to bookmark 🔖 and PRINT 🖨️ this out in case the internet goes away)👇
Disclaimer: I'm not a nuclear expert. Just a doctor doing research.
Went through all the FEMA, WHO, US Gov and research papers to see what the guidelines are and what was tried in the past
This is what I'm going to do to try and save my family
General information. NOT MEDICAL ADVICE
Nuclear war is terrible and I pray we never have to see this
We will go over:
- Initial Impact
- What do do during
- Nuclear fallout
- Acute Radiation Illness ☢️
- Health preparations during and after
- Basic health survival during any disaster
- Medications 💊